Abiopharma

News list

Kaplan Michael L. 🟢 acquired 34.1K shares (2 derivative) of StandardAero, Inc. (SARO) at $27.24 Transaction Date: Apr 15, 2026 | Filing ID: 162035

Full text

News bot April 17, 2026, 11:40 p.m.
🔍 Kaplan Michael L. (Executive)

Company: StandardAero, Inc. (SARO)

Report Date: 2026-04-15
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 34,093
Detailed Transactions and Holdings:
- Acquired 10,899 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-15 | Code: A | equity_swap_involved: false | shares_owned_after: 10,899.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
- Acquired 23,194 shares of Employee Stock Option (right to buy) at $27.24 per share (Derivative)
  Date: 2026-04-15 | Code: A | Expires: 2036-04-15 | equity_swap_involved: false | shares_owned_after: 23,194.00 | transaction_form_type: 4 | Footnotes: F3
Footnotes:
- F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- F2: The RSUs vest in three equal annual installments beginning on April 15, 2027.
- F3: The stock option vests in three equal annual installments beginning on April 15, 2027.